In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
We are very excited to launch our new website! Please take a few moments to click around and explore...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...